# VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)

> **NCT04757766** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 350 (actual)

## Conditions studied

- Chronic Venous Insufficiency

## Interventions

- **DRUG:** in daily everyday routine practice

## Key facts

- **NCT ID:** NCT04757766
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04757766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04757766, "VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04757766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*